BB Biotech AG (LSE:0JYO) Scaled Net Operating Assets : 1.04 (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is BB Biotech AG Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BB Biotech AG's operating assets for the quarter that ended in Mar. 2024 was €2,927.5 Mil. BB Biotech AG's operating liabilities for the quarter that ended in Mar. 2024 was €9.6 Mil. BB Biotech AG's Total Assets for the quarter that ended in Dec. 2023 was €2,796.3 Mil. Therefore, BB Biotech AG's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 1.04.

BB Biotech AG Scaled Net Operating Assets Historical Data

The historical data trend for BB Biotech AG's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Scaled Net Operating Assets Chart

BB Biotech AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

1.18

1.12

0.95

0.88

0.90

BB Biotech AG Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Dec17	Dec18	Dec19	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.85	1.01	0.99	1.06	1.04

Competitive Comparison of BB Biotech AG's Scaled Net Operating Assets

For the Biotechnology subindustry, BB Biotech AG's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BB Biotech AG's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Scaled Net Operating Assets falls into.

BB Biotech AG Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BB Biotech AG's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(2795.804	-	9.5820000000001)	/	3094.031
=	0.90

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2796.335	-	0.531
=	2795.804

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	332.886	-	323.304	-	0
=	9.5820000000001

BB Biotech AG's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(2927.525	-	9.622)	/	2796.335
=	1.04

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2927.944	-	0.419
=	2927.525

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	366.502	-	356.88	-	0
=	9.622

BB Biotech AG Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BB Biotech AG (LSE:0JYO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (LSE:0JYO) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

BIONz:UK BBZA:Germany BION:Switzerland

Address

Schwertstrasse 6, Schaffhausen, CHE, CH-8200

Website

https://www.bbbiotech.com

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (LSE:0JYO) Headlines

No Headlines